{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["glioblastoma", "linearol", "radiation", "treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36835175", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "13"}], "Language": ["eng"], "ELocationID": ["3760", "10.3390/ijms24043760"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "13"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Therapeutic Potential of Linearol in Combination with Radiotherapy for the Treatment of Glioblastoma In Vitro.", "Abstract": {"AbstractText": ["Glioblastoma is one of the most malignant and lethal forms of primary brain tumors in adults. Linearol, a kaurane diterpene isolated from different medicinal plants, including those of the genus Sideritis, has been found to possess significant anti-oxidant, anti-inflammatory and anti-microbial properties. In this study, we aimed to determine whether linearol could exhibit anti-glioma effects when given alone or in combination with radiotherapy in two human glioma cell lines, U87 and T98. Cell viability was examined with the Trypan Blue Exclusion assay, cell cycle distribution was tested with flow cytometry, and the synergistic effects of the combination treatment were analyzed with CompuSyn software. Linearol significantly suppressed cell proliferation and blocked cell cycle at the S phase. Furthermore, pretreatment of T98 cells with increasing linearol concentrations before exposure to 2 Gy irradiation decreased cell viability to a higher extent than linearol or radiation treatment alone, whereas in the U87 cells, an antagonistic relationship was observed between radiation and linearol. Moreover, linearol inhibited cell migration in both tested cell lines. Our results demonstrate for the first time that linearol is a promising anti-glioma agent and further studies are needed to fully understand the underlying mechanism of this effect."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece."}, {"Identifier": [], "Affiliation": "Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Zoi", "ForeName": "Vasiliki", "Initials": "V"}, {"Identifier": ["0000-0002-6081-7632"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece."}], "LastName": "Papagrigoriou", "ForeName": "Theodora", "Initials": "T"}, {"Identifier": ["0000-0002-8929-656X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece."}], "LastName": "Tsiftsoglou", "ForeName": "Olga S", "Initials": "OS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece."}, {"Identifier": [], "Affiliation": "Department of Neurosurgery, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Alexiou", "ForeName": "George A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece."}, {"Identifier": [], "Affiliation": "Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Giannakopoulou", "ForeName": "Maria", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Tzima", "ForeName": "Eftychia", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Tsekeris", "ForeName": "Pericles", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Zikou", "ForeName": "Anastasia", "Initials": "A"}, {"Identifier": ["0000-0003-0370-1024"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece."}], "LastName": "Kyritsis", "ForeName": "Athanasios P", "Initials": "AP"}, {"Identifier": ["0000-0001-8864-131X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece."}], "LastName": "Lazari", "ForeName": "Diamanto", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece."}], "LastName": "Galani", "ForeName": "Vasiliki", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "linearol"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glioblastoma"}, {"QualifierName": ["pathology"], "DescriptorName": "Glioma"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["radiation effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Brain Neoplasms"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Di Martino E., Smith L., Bradley S.H., Hemphill S., Wright J., Renzi C., Bergin R., Emery J., Neal R.D. Incidence trends for twelve cancers in younger adults\u2014A rapid review. Br. J. Cancer. 2022;126:1374\u20131386. doi: 10.1038/s41416-022-01704-x.", "ArticleIdList": ["10.1038/s41416-022-01704-x", "PMC9090760", "35132237"]}, {"Citation": "Miranda-Filho A., Pi\u00f1eros M., Soerjomataram I., Deltour I., Bray F. Cancers of the brain and cns: Global patterns and trends in incidence. Neuro Oncol. 2017;19:270\u2013280. doi: 10.1093/neuonc/now166.", "ArticleIdList": ["10.1093/neuonc/now166", "PMC5464292", "27571887"]}, {"Citation": "Jov\u010devska I., Ko\u010devar N., Komel R. Glioma and glioblastoma\u2014How much do we (not) know? Mol. Clin. Oncol. 2013;1:935\u2013941. doi: 10.3892/mco.2013.172.", "ArticleIdList": ["10.3892/mco.2013.172", "PMC3916171", "24649273"]}, {"Citation": "Alexiou G.A., Tsamis K.I., Vartholomatos E., Peponi E., Tzima E., Tasiou I., Lykoudis E., Tsekeris P., Kyritsis A.P. Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. J. Neurooncol. 2015;123:217\u2013224. doi: 10.1007/s11060-015-1799-9.", "ArticleIdList": ["10.1007/s11060-015-1799-9", "25935110"]}, {"Citation": "Davis M.E. Glioblastoma: Overview of Disease and Treatment. Clin. J. Oncol. Nurs. 2016;20:2\u20138. doi: 10.1188/16.CJON.S1.2-8.", "ArticleIdList": ["10.1188/16.CJON.S1.2-8", "PMC5123811", "27668386"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Bonaf\u00e9 G.A., Boschiero M.N., Sodr\u00e9 A.R., Ziegler J.V., Rocha T., Ortega M.M. Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines? Front. Neurol. 2022;12:784330. doi: 10.3389/fneur.2021.784330.", "ArticleIdList": ["10.3389/fneur.2021.784330", "PMC8923017", "35300350"]}, {"Citation": "Zoi V., Galani V., Vartholomatos E., Zacharopoulou N., Tsoumeleka E., Gkizas G., Bozios G., Tsekeris P., Chousidis I., Leonardos I., et al. Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro. Biomedicines. 2021;9:1562. doi: 10.3390/biomedicines9111562.", "ArticleIdList": ["10.3390/biomedicines9111562", "PMC8615260", "34829791"]}, {"Citation": "Persano F., Gigli G., Leporatti S. Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas. Int. J. Mol. Sci. 2022;23:3360. doi: 10.3390/ijms23063360.", "ArticleIdList": ["10.3390/ijms23063360", "PMC8955269", "35328780"]}, {"Citation": "Gonz\u00e1lez-Burgos E., Carretero M.E., G\u00f3mez-Serranillos M.P. Sideritis spp.: Uses, chemical composition and pharmacological activities\u2014A review. J. Ethnopharmacol. 2011;135:209\u2013225. doi: 10.1016/j.jep.2011.03.014.", "ArticleIdList": ["10.1016/j.jep.2011.03.014", "21420484"]}, {"Citation": "Plants of the World Online.  [(accessed on 8 April 2020)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:21227-1."}, {"Citation": "Tadi\u0107 V.M., Jeremic I., Dobric S., Isakovic A., Markovic I., Trajkovic V., Bojovic D., Arsic I. Anti-inflammatory, gastroprotective, and cytotoxic effects of Sideritis scardica extracts. Planta Med. 2012;78:415\u2013427. doi: 10.1055/s-0031-1298172.", "ArticleIdList": ["10.1055/s-0031-1298172", "22274814"]}, {"Citation": "Jeremic I., Tadic V., Isakovic A., Trajkovic V., Markovic I., Redzic Z., Isakovic A. The mechanisms of in vitro cytotoxicity of mountain tea, Sideritis scardica, against the C6 glioma cell line. Planta Med. 2013;79:1516\u20131524. doi: 10.1055/s-0033-1350809.", "ArticleIdList": ["10.1055/s-0033-1350809", "24072501"]}, {"Citation": "Ambrosio S.R., Furtado N.A., de Oliveira D.C., da Costa F.D., Martins C.H.G., de Carvalho T.C., Porto T.S., Veneziani R.C.S. Antimicrobial activity of kaurane diterpenes against oral pathogens. Z. Nat. C J. Biosci. 2008;63:326\u2013330. doi: 10.1515/znc-2008-5-603.", "ArticleIdList": ["10.1515/znc-2008-5-603", "18669015"]}, {"Citation": "Hwang B.Y., Lee J.H., Koo T.H., Kim H.S., Hong Y.S., Ro J.S., Lee K.S., Lee J.J. Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-kappaB activation in LPS-stimulated macrophage RAW264.7 cells. Planta Med. 2001;67:406\u2013410. doi: 10.1055/s-2001-15808.", "ArticleIdList": ["10.1055/s-2001-15808", "11488452"]}, {"Citation": "de las Heras B., Hortelano S., Gir\u00f3n N., Bermejo P., Rodr\u00edguez B., Bosc\u00e1 L. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages. Br. J. Pharmacol. 2007;152:249\u2013255. doi: 10.1038/sj.bjp.0707382.", "ArticleIdList": ["10.1038/sj.bjp.0707382", "PMC1978262", "17618303"]}, {"Citation": "Kilic T., Topcu G., Goren A.C., Aydogmus Z., Karagoz A., Yildiz Y.K., Aslan I. Ent-kaurene Diterpenoids from Sideritis lycia with Antiviral and Cytotoxic Activities. Rec. Nat. Prod. 2020;14:256\u2013268. doi: 10.25135/rnp.163.19.08.1373.", "ArticleIdList": ["10.25135/rnp.163.19.08.1373"]}, {"Citation": "Castrillo A., de las Heras B., Hortelano S., Rodriguez B., Villar A., Bosca L. Inhibition of the nuclear factor kB (NF-kB) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-kB-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem. 2001;276:15854\u201315860. doi: 10.1074/jbc.M100010200.", "ArticleIdList": ["10.1074/jbc.M100010200", "11278990"]}, {"Citation": "Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J.B., Belanger K., Brandes A.A., Marosi C., Bogdahn U., et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N. Engl. J. Med. 2005;352:987\u2013996. doi: 10.1056/NEJMoa043330.", "ArticleIdList": ["10.1056/NEJMoa043330", "15758009"]}, {"Citation": "Yabo Y.A., Niclou S.P., Golebiewska A. Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro Oncol. 2022;24:669\u2013682. doi: 10.1093/neuonc/noab269.", "ArticleIdList": ["10.1093/neuonc/noab269", "PMC9071273", "34932099"]}, {"Citation": "Ma R., Taphoorn M.J.B., Plaha P. Advances in the management of glioblastoma. J. Neurol. Neurosurg. Psychiatry. 2021;92:1103\u20131111. doi: 10.1136/jnnp-2020-325334.", "ArticleIdList": ["10.1136/jnnp-2020-325334", "34162730"]}, {"Citation": "Sestito S., Runfola M., Tonelli M., Chiellini G., Rapposelli S. New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective. Front. Pharmacol. 2018;9:874. doi: 10.3389/fphar.2018.00874.", "ArticleIdList": ["10.3389/fphar.2018.00874", "PMC6085564", "30123135"]}, {"Citation": "Akter R., Najda A., Rahman H., Shah M., Weso\u0142owska S., Hassan S.S.U., Mubin S., Bibi P., Saeeda S. Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives. Molecules. 2021;26:5997. doi: 10.3390/molecules26195997.", "ArticleIdList": ["10.3390/molecules26195997", "PMC8512367", "34641542"]}, {"Citation": "Zoi V., Galani V., Tsekeris P., Kyritsis A.P., Alexiou G.A. Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers. Biomedicines. 2022;10:312. doi: 10.3390/biomedicines10020312.", "ArticleIdList": ["10.3390/biomedicines10020312", "PMC8869399", "35203521"]}, {"Citation": "Bellettato C.M., Scarpa M. Possible strategies to cross the blood\u2013brain barrier. Ital. J. Pediatr. 2018;44:127\u2013133. doi: 10.1186/s13052-018-0563-0.", "ArticleIdList": ["10.1186/s13052-018-0563-0", "PMC6238258", "30442184"]}, {"Citation": "Patrignani F., Prasad S., Novakovic M., Marin P.D., Bukvicki D. Lamiaceae in the treatment of cardiovascular diseases. Front. Biosci. 2021;26:612\u2013643. doi: 10.2741/4909.", "ArticleIdList": ["10.2741/4909", "33049685"]}, {"Citation": "Khoury M., Stien D., Eparvier V., Ouaini N., Beyrouthy M.E.L. Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils. Evid.-Based Complement. Altern. Med. 2016;2016:2547169. doi: 10.1155/2016/2547169.", "ArticleIdList": ["10.1155/2016/2547169", "PMC5178328", "28053641"]}, {"Citation": "Bekut M., Brki\u0107 S., Kladar N., Dragovi\u0107 G., Gavari\u0107 N., Bo\u017ein B. Potential of selected Lamiaceae plants in anti(retro)viral therapy. Pharmacol. Res. 2018;133:301\u2013314. doi: 10.1016/j.phrs.2017.12.016.", "ArticleIdList": ["10.1016/j.phrs.2017.12.016", "PMC7129285", "29258916"]}, {"Citation": "Raja R.R. Medicinally potential plants of Labiatae (Lamiaceae) family: An overview. Res. J. Med. Plants. 2012;6:203\u2013213. doi: 10.3923/rjmp.2012.203.213.", "ArticleIdList": ["10.3923/rjmp.2012.203.213"]}, {"Citation": "World Health Organization . WHO Traditional Medicine Strategy: 2014\u20132023. World Health Organization; Geneva, Switzerland: 2013."}, {"Citation": "Natsume A., Ishii D., Wakabayashi T. IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res. 2005;65:7573\u20137579. doi: 10.1158/0008-5472.CAN-05-0036.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-0036", "16140920"]}, {"Citation": "Alonso M.M., Gomez-Manzano C., Bekele B.N., Yung W.K., Fueyo J. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007;67:11499\u201311504. doi: 10.1158/0008-5472.CAN-07-5312.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5312", "18089777"]}, {"Citation": "Montaldi A.P., Godoy P.R., Sakamoto-Hojo E.T. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2015;793:19\u201329. doi: 10.1016/j.mrgentox.2015.06.001.", "ArticleIdList": ["10.1016/j.mrgentox.2015.06.001", "26520369"]}, {"Citation": "Puliyappadamba V.T., Hatanpaa K.J., Chakraborty S., Habib A.A. The role of NF-\u03baB in the pathogenesis of glioma. Mol. Cell Oncol. 2014;1:e963478. doi: 10.4161/23723548.2014.963478.", "ArticleIdList": ["10.4161/23723548.2014.963478", "PMC4905061", "27308348"]}, {"Citation": "Nogueira L., Ruiz-Onta\u00f1on P., Vazquez-Barquero A., Lafarga M., Berciano M.T., Aldaz M., Grande L., Casafont I., Segura V., Robles E.F., et al. Blockade of the NF\u03baB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo. Oncogene. 2011;30:3537\u20133548. doi: 10.1038/onc.2011.74.", "ArticleIdList": ["10.1038/onc.2011.74", "21423202"]}, {"Citation": "Robe P.A., Bentires-Alj M., Bonif M., Rogister B., Deprez M., Haddada H., Khac M.T., Jolois O., Erkmen K., Merville M.P., et al. In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin. Cancer Res. 2004;10:5595\u20135603. doi: 10.1158/1078-0432.CCR-03-0392.", "ArticleIdList": ["10.1158/1078-0432.CCR-03-0392", "15328202"]}, {"Citation": "Wang H., Wang H., Zhang W., Huang H.J., Liao W.S., Fuller G.N. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab. Invest. 2004;84:941\u2013951. doi: 10.1038/labinvest.3700123.", "ArticleIdList": ["10.1038/labinvest.3700123", "15184909"]}, {"Citation": "Levin V., Maor M., Thall P., Yung W., Bruner J., Sawaya R., Kyritsis A., Leeds N., Woo S., Rodr\u00edguez L., et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 1995;30:357\u2013364. doi: 10.1016/0360-3016(95)00160-Z.", "ArticleIdList": ["10.1016/0360-3016(95)00160-Z", "7673023"]}, {"Citation": "Lee H.C., Kim D.W., Jung K.Y., Park I.C., Park M.J., Kim M.S., Woo S.H., Rhee C.H., Yoo H., Lee S.H., et al. Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int. J. Mol. Med. 2004;13:883\u2013887. doi: 10.3892/ijmm.13.6.883.", "ArticleIdList": ["10.3892/ijmm.13.6.883", "15138630"]}, {"Citation": "Olivier C., Oliver L., Lalier L., Vallette F.M. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Front. Mol. Biosci. 2021;7:620677. doi: 10.3389/fmolb.2020.620677.", "ArticleIdList": ["10.3389/fmolb.2020.620677", "PMC7873048", "33585565"]}, {"Citation": "Traverso N., Ricciarelli R., Nitti M., Marengo B., Furfaro A.L., Pronzato M.A., Marinari U.M., Domenicotti C. Role of glutathione in cancer progression and chemoresistance. Oxid. Med. Cell Longev. 2013;2013:972913. doi: 10.1155/2013/972913.", "ArticleIdList": ["10.1155/2013/972913", "PMC3673338", "23766865"]}, {"Citation": "Gonz\u00e1lez-Burgos E., Carretero M.E., G\u00f3mez-Serranillos M.P. Involvement of Nrf2 signaling pathway in the neuroprotective activity of natural kaurane diterpenes. Neuroscience. 2013;231:400\u2013412. doi: 10.1016/j.neuroscience.2012.10.018.", "ArticleIdList": ["10.1016/j.neuroscience.2012.10.018", "23079631"]}, {"Citation": "Gonz\u00e1lez-Burgos E., Duarte A.I., Carretero M.E., Moreira P.I., G\u00f3mez-Serranillos M.P. Kaurane diterpenes as mitochondrial alterations preventive agents under experimental oxidative stress conditions. Pharm. Biol. 2016;54:705\u2013711. doi: 10.3109/13880209.2015.1072829.", "ArticleIdList": ["10.3109/13880209.2015.1072829", "26427521"]}, {"Citation": "Gonz\u00e1lez-Burgos E., Carretero M.E., G\u00f3mez-Serranillos M.P. In vitro permeability study of CNS-active diterpenes from Sideritis spp. using cellular models of blood-brain barrier. Planta Med. 2013;79:1545\u20131551. doi: 10.1055/s-0033-1350797.", "ArticleIdList": ["10.1055/s-0033-1350797", "24030291"]}, {"Citation": "Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. 2006;1:2315\u20132319. doi: 10.1038/nprot.2006.339.", "ArticleIdList": ["10.1038/nprot.2006.339", "17406473"]}, {"Citation": "Stahl E. Thin-Layer Chromatography. Springer; Berlin/Heidelberg, Germany: New York, NY, USA: 1969."}, {"Citation": "Baser K.H.C., Bondi M.L., Bruno M., Kirimer N., Piozzi F., Tumen G., Vassallo N. An ent-kaurane from Sideritis huber-morathii. Phytochemistry. 1996;43:1293\u20131295. doi: 10.1016/S0031-9422(96)00371-8.", "ArticleIdList": ["10.1016/S0031-9422(96)00371-8"]}, {"Citation": "Kastamoulas M., Chondrogiannis G., Kanavaros P., Vartholomatos G., Bai M., Briasoulis E., Arvanitis D., Galani V. Cytokine effects on cell survival and death of A549 lung carcinoma cells. Cytokine. 2013;61:816\u2013825. doi: 10.1016/j.cyto.2013.01.017.", "ArticleIdList": ["10.1016/j.cyto.2013.01.017", "23433788"]}, {"Citation": "Chou T.C. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol. Rev. 2006;58:621\u2013681. doi: 10.1124/pr.58.3.10.", "ArticleIdList": ["10.1124/pr.58.3.10", "16968952"]}, {"Citation": "Chou T.C. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method. Cancer Res. 2010;70:440\u2013446. doi: 10.1158/0008-5472.CAN-09-1947.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1947", "20068163"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "20"}, {"Year": "2023", "Month": "2", "Day": "3"}, {"Year": "2023", "Month": "2", "Day": "8"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "2", "Minute": "47"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["36835175", "PMC9958920", "10.3390/ijms24043760", "ijms24043760"]}}], "PubmedBookArticle": []}